Abstract
Background Antidepressant use is common in people with dementia. Antidepressants may be started to manage symptoms of dementia, rather than depressive and anxiety disorders. We hypothesised people prescribed antidepressants around the time of dementia diagnosis may have different characteristics from those with longstanding prescriptions.
Methods We used linked primary care (Lambeth DataNet) and specialist (Clinical Record Interactive Search) data for patients with dementia in south London, UK. Antidepressant prescription was ascertained, and a new start was within one year before or after dementia diagnosis. Coded fields, a rating scale for neuropsychiatric symptoms and natural language processing of full-text were used to describe depression and anxiety.
Results Of 3,713 patients with dementia, 28% were prescribed antidepressants within the year of dementia diagnosis, and 42% of these were new start prescriptions. Compared to the no antidepressant group, the new start group were more likely to be female, have vascular dementia and neuropsychiatric symptoms. Compared to the long-standing group, new start had fewer comorbidities; people from non-White ethnicities were more likely to lack documentation of depression or anxiety. Deprescribing was equally unlikely in new and long-term prescriptions (6.3% vs 5.5% per year of follow-up).
Conclusions The high incidence of new prescribing, as well as the lack of deprescribing, points to unmet needs and a role for more proactive medication review. Further studies should include the clinician and patient voices to further understand how to improve non-pharmacological support for people at the threshold of dementia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
KD, CM and RS are part-funded by the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC). Additional funding: KD is supported by the SPIN-Dementia Network+ (https://spindementianet.org/). RS is supported by the NIHR Applied Research Collaboration South London, DATAMIND HDR UK Mental Health Data Hub (MRC reference:MR/W014386) and the UK Prevention Research Partnership (Violence, Health and Society; MR-VO49879/1). CM is supported by the NIHR HealthTech Research Centre in Brain Health. BPM has received funding from the Department of Psychiatry at Lausanne University Hospital (CHUV) and a Tremplin Grant (University of Lausanne) for academic development and protected research time.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The CRIS oversight committee of South London and Maudsley NHS Trust gave approval for this study via secondary analysis of CRIS. The LDN oversight committee of Lambeth Together partnership gave approval for this study via secondary analysis of CRIS. National Research Ethics Service Committee South Central Oxford C of UKs Health Research Authority gave ethical approval to Clinical Records Interactive Search (CRIS) at South London and Maudsley and its linkages as an anonymised data source for secondary analysis ref: 18/SC/0372.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The data used in this study are available at CRIS at South London and Maudsley BRC hub, but restrictions apply for data confidentiality, see https://www.maudsleybrc.nihr.ac.uk/facilities/clinical-record-interactive-search-cris/information-for-researchers/
